Monitor for future financial restatements or material weaknesses in internal controls given the auditor resignation and delayed filings. The addition of a Clawback Policy and new audit committee chair suggests governance reforms are underway, but the sequence of events signals underlying financial reporting issues.
Price Chart
Executive Summary
Wellgistics Health, Inc. filed an amended 10-K to restate Part III, Items 10 and 12, which cover director/executive officer information and security ownership, and to add its Clawback Policy to exhibits. This follows a prior late filing (NT 10-Q) due to auditor resignation, raising concerns about governance and financial reporting integrity.
Key Facts
- Amendment restates Part III, Items 10 and 12, which include director/executive officer details and beneficial ownership disclosures
- Adds Clawback Policy to exhibits, indicating heightened governance scrutiny
- Follows a late 10-Q filing due to auditor resignation (UHY LLP) and transition to new auditor Suri & Co.
- No financial restatements were made in this amendment, but governance changes are material
- Company recently appointed Gary Herman as director and audit committee chair, a seasoned investor with turnaround experience
Financial Impact
No direct financial impact from this amendment, but auditor change and delayed filings increase regulatory and litigation risk
Risk Factors
- Increased risk of SEC inquiry or enforcement due to late filings and auditor change
- Potential shareholder litigation related to disclosure delays or governance lapses
- Further financial restatements possible if new auditor identifies material errors
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 10-K/A Filing (Primary) | 0001493152-26-018958 |
| Document: 0001493152-26-018958-index-headers.html | 0001493152-26-018958 |
| Document: 0001493152-26-018958-index.html | 0001493152-26-018958 |
| Document: 0001493152-26-018958.txt | 0001493152-26-018958 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | S-1/A | — | awaiting T+20 | — | — |
May 29, 2026 21w ago | 8-K | $3.85 $3.10 | ▲ +19.48% | ▲ +18.18% | — |
May 21, 2026 22w ago | 8-K | $5.35 $3.18 | ▼ −40.52% | ▼ −40.85% | — |
May 19, 2026 22w ago | 8-K | $6.45 $3.39 | ▼ −47.44% | ▼ −48.18% | — |
May 19, 2026 23w ago | 8-K | $8.40 $3.70 | ▼ −55.95% | ▼ −56.94% | — |
May 18, 2026 23w ago | 8-K | $8.70 $3.69 | ▼ −57.59% | ▼ −59.17% | — |
May 8, 2026 24w ago | EFFECT | $4.21 $4.35 | ▼ −3.33% | ▼ −3.30% | — |
Apr 24, 2026 26w ago | 10-K/A | $6.23 $3.82 | ▲ +38.68% | ▲ +43.64% | — |
Apr 17, 2026 27w ago | 8-K | $6.60 $8.70 | ▲ +31.82% | ▲ +27.62% | — |
Apr 15, 2026 27w ago | S-3 | $7.37 $4.70 | ▼ −36.18% | ▼ −42.82% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers